FORA Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,439
| Closed | -$939K | – | 446 |
|
|
2024
Q2 | $939K | Sell |
3,439
-2,570
| -43% | -$702K | 0.11% | 222 |
|
|
2024
Q1 | $2.08M | Sell |
6,009
-236
| -4% | -$81.6K | 0.17% | 155 |
|
|
2023
Q4 | $2.02M | Buy |
6,245
+3,562
| +133% | +$1.15M | 0.17% | 160 |
|
|
2023
Q3 | $962K | Sell |
2,683
-1,352
| -34% | -$485K | 0.08% | 251 |
|
|
2023
Q2 | $1.53M | Buy |
4,035
+3,226
| +399% | +$1.22M | 0.22% | 124 |
|
|
2023
Q1 | $388K | Sell |
809
-760
| -48% | -$364K | 0.04% | 397 |
|
|
2022
Q4 | $660K | Buy |
1,569
+400
| +34% | +$168K | 0.11% | 227 |
|
|
2022
Q3 | $488K | Buy |
+1,169
| New | +$488K | 0.09% | 256 |
|
|
2022
Q2 | – | Sell |
-1,931
| Closed | -$1.12M | – | 435 |
|
|
2022
Q1 | $1.12M | Buy |
+1,931
| New | +$1.12M | 0.2% | 144 |
|
|
2021
Q2 | – | Sell |
-340
| Closed | -$194K | – | 886 |
|
|
2021
Q1 | $194K | Buy |
+340
| New | +$194K | 0.06% | 294 |
|